STOCK TITAN

Nu Skin Enter Stock Price, News & Analysis

NUS NYSE

Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.

Nu Skin Enterprises, Inc. (NYSE: NUS) is an integrated beauty and wellness company whose news flow centers on product innovation, device launches, financial performance and global expansion. The company’s public updates highlight its focus on beauty and wellness device systems, nutritional products and anti-aging brands sold through a dynamic affiliate opportunity platform in nearly 50 markets worldwide.

News about Nu Skin often includes announcements of quarterly and full-year financial results, where management discusses revenue, earnings per share, regional performance and non-GAAP metrics such as constant-currency revenue change and adjusted EPS. These releases are frequently accompanied by conference call and webcast details, giving context on operating trends, segment results for the Nu Skin and Rhyz businesses, and guidance ranges.

Another key category of NUS news involves product and technology developments. Recent communications have featured the introduction of Prysm iO, an AI-powered intelligent nutritional wellness platform that measures carotenoid levels through a non-invasive finger scan and connects with Prysm-certified supplements. Nu Skin also issues updates about its portfolio of beauty and wellness device systems and recognition from third parties, such as rankings from Euromonitor International Ltd. for at-home beauty and wellness device systems.

Investors and followers of NUS can also expect news on strategic initiatives, including pre-market and launch activities in emerging markets like India, and commentary on regional trends such as growth in Latin America. Conference participation, moderated fireside chats and strategy discussions at industry events are additional sources of information on the company’s direction. Bookmark this page to monitor Nu Skin’s earnings releases, device and product announcements, geographic expansion updates and other material developments reflected in its news coverage.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
management
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
none
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) announced the resignation of CFO Mark Lawrence, effective March 31, 2023, to pursue other opportunities. Lawrence will continue as a senior advisor until April 2023 to ensure a smooth transition. The board has appointed James D. Thomas, previously the chief accounting officer, as interim CFO while searching for a permanent replacement. The company reaffirmed its first-quarter and annual guidance for 2023, initially provided on February 15, 2023. Nu Skin will release its Q1 results on May 3, 2023, followed by a conference call with investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
management
Rhea-AI Summary

Nu Skin Enterprises, Inc. (NYSE: NUS) reported Q4 2022 revenue of $522.3 million, down 22% year-over-year, impacted by foreign exchange (FX) losses of $51 million. EPS for the quarter was $1.15, improving from a loss of $(0.18) in Q4 2021. For FY 2022, revenue totaled $2.23 billion, down 17%. Looking ahead, Q1 2023 revenue is projected between $450 to $490 million, a decline of 26% to 19%. Annual revenue guidance for 2023 ranges from $2.03 billion to $2.18 billion. The company anticipates ongoing macroeconomic challenges but remains optimistic about its long-term strategy and growth prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags

FAQ

What is the current stock price of Nu Skin Enter (NUS)?

The current stock price of Nu Skin Enter (NUS) is $7.47 as of April 22, 2026.

What is the market cap of Nu Skin Enter (NUS)?

The market cap of Nu Skin Enter (NUS) is approximately 367.4M.